Archived Newsletters

41. 10.06.25 -- You're In Charge Of Strategic Sourcing? What's That Actually Mean? 10/6/2025
    10/06/25 Outsourced Pharma Newsletter
42. 10.03.25 -- End-To-End Support For Biologic API And Drug Product Development 10/3/2025
    10/03/25 Outsourced Pharma Newsletter
43. 10.03.25 -- Why Pharma, Medical Device Risks Must Be Analyzed By Their Risk Mechanisms 10/3/2025
    10/03/25 Outsourced Pharma Newsletter
44. 10.02.25 -- New Podcast Episodes: Tackling Alzheimer's Disease, Dye Drug Conjugates For Cancer, FDA Fridays 10/2/2025
    10/02/25 Outsourced Pharma Newsletter
45. 10.02.25 -- Why Process Safety Matters — And What's Next For Pharma Manufacturing 10/2/2025

    10/02/25 Outsourced Pharma Newsletter

46. 10.02.25 -- Execute Or Decay: Radiopharma's Outsourcing Reality 10/2/2025
    10/02/25 Outsourced Pharma Newsletter
47. 10.01.25 -- Gain Access To Tailored Bioanalytic Services. 10/1/2025
    10/01/25
48. 10.01.25 -- How Can Nanotechnology Transform Drug Delivery? 10/1/2025

    10/01/25 Outsourced Pharma Newsletter

49. 10.01.25 -- You're In Charge Of Strategic Sourcing? What's That Actually Mean? 10/1/2025
    10/01/25 Outsourced Pharma Newsletter
50. 09.30.25 -- From Single-Use To Continuous Manufacturing: Strategies Shaping Biopharma 9/30/2025

    09/30/25 Outsourced Pharma Newsletter